BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9883481)

  • 1. Remarkable difference in the incidence of liver tumors by N-nitrosodimethylamine in carcinogen-resistant DRH rat and its parental strain Donryu rat.
    Yan Y; Higashi K; Tanimoto A; Fukamachi Y; Itoh H; Abe T; Higashi T
    J UOEH; 1998 Dec; 20(4):307-14. PubMed ID: 9883481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.
    Yan Y; Higashi K; Yamamura K; Fukamachi Y; Abe T; Gotoh S; Sugiura T; Hirano T; Higashi T; Ichiba M
    Jpn J Cancer Res; 1998 Aug; 89(8):806-13. PubMed ID: 9765615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats.
    Denda A; Kitayama W; Konishi Y; Yan Y; Fukamachi Y; Miura M; Gotoh S; Ikemura K; Abe T; Higashi T; Higashi K
    Cancer Lett; 1999 Jun; 140(1-2):59-67. PubMed ID: 10403542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of possible involvement of several genes related to development of hepatocarcinogenesis in rats.
    Todaka N; Higashi K; Yan Y; Abe T; Yamashiro K; Hiai H
    J UOEH; 2000 Jun; 22(2):119-32. PubMed ID: 10862407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blunt cell growth potential in carcinogen resistant inbred DRH rats.
    Yamashiro K; Yan Y; Fukamachi Y; Gotoh S; Higashi K; Ohtsuki M; Hamada Y; Higashi T
    Exp Anim; 2000 Jan; 49(1):47-50. PubMed ID: 10803362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the multidrug resistance gene expression in the livers of rats associated with different susceptibility of hepatocarcinogenesis.
    Gotoh S; Todaka N; Yan Y; Fukamachi Y; Abe T; Higashi K
    J UOEH; 1999 Dec; 21(4):265-76. PubMed ID: 10629898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats.
    Mise-Omata S; Sugiura T; Higashi K; Yamashita U
    Jpn J Cancer Res; 1999 Dec; 90(12):1277-84. PubMed ID: 10665643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the microsomal cytochrome P450s in the livers of carcinogen-resistant and sensitive rats during long-term administration of 3'-methyl-4-dimethylaminoazobenzene.
    Yang M; Yamamura K; Yan Y; Fukamachi Y; Hirano T; Kawamoto T; Higashi K
    J UOEH; 1997 Dec; 19(4):277-86. PubMed ID: 9431579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain.
    Higashi K; Denda A; Higashi T; Hiai H
    Comp Med; 2004 Aug; 54(4):373-7. PubMed ID: 15357316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low selection of preneoplastic hepatocytes after treatment with the 2-acetylaminofluorene diet-partial hepatectomy regimen in the liver of hepatocarcinogenesis-resistant DRH strain rats.
    Imai K; Yamamoto M; Tanaka H; Hashimoto N; Miyakoshi M; Honmou S; Yoshie M; Tamakawa S; Yaginuma Y; Kasai S; Ogawa K
    Oncol Rep; 2007 Jan; 17(1):55-60. PubMed ID: 17143478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH strain rats.
    Zeng ZZ; Higashi S; Kitayama W; Denda A; Yan Y; Matsuo K; Konishi Y; Hiai H; Higashi K
    Cancer Res; 2000 Jun; 60(11):2876-81. PubMed ID: 10850431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low p38 MAPK and JNK activation in cultured hepatocytes of DRH rats; a strain highly resistant to hepatocarcinogenesis.
    Honmo S; Ozaki A; Yamamoto M; Hashimoto N; Miyakoshi M; Tanaka H; Yoshie M; Tamakawa S; Tokusashi Y; Yaginuma Y; Kasai S; Ogawa K
    Mol Carcinog; 2007 Sep; 46(9):758-65. PubMed ID: 17546627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of resistant Drh1 locus in chemical carcinogen-induced hepatocarcinogenesis in rats: analysis with a speed congenic strain.
    Liu H; Higashi K; Hiai H
    Cancer Sci; 2005 Mar; 96(3):164-9. PubMed ID: 15771619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat.
    Gotow T; Shiozaki M; Higashi T; Yoshimura K; Shibata M; Kominami E; Uchiyama Y
    Histochem Cell Biol; 2008 Sep; 130(3):583-94. PubMed ID: 18633633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage.
    Yan Y; Zeng ZZ; Higashi S; Denda A; Konishi Y; Onishi S; Ueno H; Higashi K; Hiai H
    Carcinogenesis; 2002 Jan; 23(1):189-96. PubMed ID: 11756240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants.
    Yoshimoto F; Masuda S; Higashi T; Nishii T; Takamisawa I; Tateishi N; Sakamoto Y
    Cancer Res; 1985 Dec; 45(12 Pt 1):6155-9. PubMed ID: 3933822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The occurrence of polymorphism of mannose 6-phosphate/insulin-like growth factor 2 receptor gene in laboratory and wild rats.
    Yan Y; Todaka N; Yamamura K; Hirano H; Gotoh S; Katoh T; Higashi K; Arai S; Murata Y; Higashi T; Jirtle RL
    J UOEH; 1999 Sep; 21(3):199-208. PubMed ID: 10589458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenicity of 3'-hydroxymethyl, 3'-formyl, and 3'-carboxy derivatives of 4-(dimethylamino)azobenzene in rat liver.
    Mori Y; Nagai H; Hori T; Niwa T; Toyoshi K; Koda A; Kawada K; Ojima A
    Gan; 1981 Feb; 72(1):160-5. PubMed ID: 6791985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of oxidative DNA damage and its repair activity in the livers of 3'-methyl-4-dimethylaminoazobenzene-treated rodents.
    Hirano T; Higashi K; Sakai A; Tsurudome Y; Ootsuyama Y; Kido R; Kasai H
    Jpn J Cancer Res; 2000 Jul; 91(7):681-5. PubMed ID: 10920274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose responses of five hepatocarcinogens for the initiation of rat hepatocarcinogenesis.
    Imaida K; Shirai T; Tatematsu M; Takano T; Ito N
    Cancer Lett; 1981 Dec; 14(3):279-83. PubMed ID: 6800641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.